MACROH2A1 and teratoma: Ectopic macroH2A1 over-expression reduces the metastatic potential of melanoma and hepatocellular carcinoma (HCC) [31,32,33], whereas macroH2A1 depletion increases the aggressiveness of HCC, teratoma, and breast cancer cells [32,34,35].